Eidos is a preclinical stage company focused on treatment of the orphan disease familial amyloid cardiomyopathy (FAC), which is caused by deposition of a destabilized form of the serum protein transthyretin (TTR) and senile systemic amyloidosis (SSA). The lead molecule, AG10 is an orally bioavailable kinetic stabilizer of TTR whose potency and selectivity in human … Continue reading Eidos Therapeutics
CardioDx is a personalized medicine company that develops and commercializes genetic based cardiac diagnostic tests. The company is currently developing several molecular diagnostics that will help physicians determine appropriate treatment for cardiovascular patients. CardioDx is using both genetics and genomics technologies to develop these unique diagnostic products. The company was formed in 2004 and is … Continue reading CardioDX, Inc.
BioSpyder Technologies has developed a novel product for targeted sequencing called TempO-Seq™, a gene expression profiling tool designed to monitor hundreds to thousands of genes at once in high throughput. TempO-Seq can analyze expression in samples with thousands of cells or from single cells without pre-amplification, maximizing utilization of precious or limited samples. Sample barcoding, … Continue reading Biospyder Technologies, Inc